In a special reprise edition of FS Insider, Jim welcomes back Dr. Andrew Lo, Professor of Finance at the MIT Sloan School of Management and the director of MIT’s Laboratory for Financial Engineering. They discuss Professor Lo’s proposal to use financial engineering to spread risks among investors and provide financial incentives to develop successful cancer treatments.
Andrew Lo: Will Financial Engineering Cure Cancer?
Mangrove Partners Narrowly Avoids “Extinction-Level Event”
Nathaniel August's Mangrove Partners is having a rough 2020. According to a copy of the hedge fund's August update, a copy of which ValueWalk has been able to review, for the year to August 5, Mangrove Funds have returned -38%. Over the trailing 12-month period, the funds returned -44%. The S&P 500 produced a positive Read More